发明名称 BOURVADIN DERIVATIVES AND THERAPEUTIC USES THEREOF
摘要 The present invention is directed at bouvardin analogs arid related compounds for the treatment of disorders including cancer. Provided herein are bouvardin analogs and related compounds, pharmaceutical compositions and kits comprising at least one bouvardin analog or related compound, and methods for treating disorders including cancer. In some aspects the compounds inhibit translation elongation at the ribosome. The compounds are used in combination with radiation therapy or with known chemotherapeutic compositions.
申请公布号 US2015238562(A1) 申请公布日期 2015.08.27
申请号 US201314380361 申请日期 2013.02.21
申请人 SU Tin Tin;GLADSTONE Mara N.;ZHANG Gan;SAMMAKIA Tarek 发明人 Su Tin Tin;Gladstone Mara N.;Zhang Gan;Sammakia Tarek
分类号 A61K38/12;A61K45/06;C07K7/64 主分类号 A61K38/12
代理机构 代理人
主权项 1. A compound of Formula I: Wherein: R1, R2, R3, R3a and R3b are independently selected from the group consisting of H, halogen, hydroxyl, C1-8 alkyl, C1-8 haloalkyl, heteroalkyl, C3-8 cycloalkyl, amino, cyano, nitro, aryl, heteroaryl, aminoacyl and acylamino; R4 is selected from the group consisting of H, C1-8 alkyl, C1-8 haloalkyl, C3-8 cycloalkyl, heteroalkyl, aryl and heteroaryl; R5, R6 and R7 are independently selected from the group consisting of H, C1-8 alkyl, C1-8 haloalkyl, heteroalkyl, C3-8 cycloalkyl, alkyl carboxylic acid, alkylaryl, alkylheteroaryl, aryl and heteroaryl; R8, R9, R10, R11, R12 and R13 are independently selected from the group consisting of H, C1-8 alkyl, heteroalkyl, aryl, heteroaryl, C1-8 haloalkyl and C3-8 cycloalkyl; or a pharmaceutically acceptable salt thereof, with the proviso that the compound is not selected from natural products RA-I, RA-II, RA-III, RA-IV, deoxybouvardin(RA-V), RA-VII, RA-VIII, RA-X, RA-XI, RA-XII, RA-XIII and the following:
地址 US